Dr. Malathi Lakshmikumaran, Director & Practice Head of IPR, Lakshmikumaran & Sridharan, will address the delegates on 6 December, 2013 and discuss the topics like:
- Plant variety protection in India - recent developments
- The new examination guidelines for biotech patents of the Indian Patent Office: implications for plant-related inventions
- The difficult year 2013: the impact of the Novartis‘ Gleevec case and Bayer‘s Nexavar case on the industry
- India‘s Biological Diversity Act 2002 - where it stands after ten years
- PVR infringement through licensing of unprotected plant variety?
- Listing requirement of varieties for marketing of seed
- Collision of trademarks and variety denominations
- The Industry Licensing Platform: Mechanisms and Synergies
- Enforceability of post-sale restrictions in view of ‘Mallinckrodt’ and ‘Quanta’
- Patentability of products isolated from nature (e.g., plant compounds, bacteria)
- Framework and Best Practice for Plant Innovation Protection
- Distinction Between Process and Product in the Radish-Sprout Cases